Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

78.23
-1.5800-1.98%
Post-market: 78.230.00000.00%16:04 EDT
Volume:947.53K
Turnover:74.35M
Market Cap:6.93B
PE:-28.72
High:79.89
Open:79.44
Low:77.51
Close:79.81
52wk High:80.97
52wk Low:25.25
Shares:88.64M
Float Shares:64.73M
Volume Ratio:1.27
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:6.74
PE(LYR):-37.56

Loading ...

CG Oncology Says Phase 3 Bond-003 Data for Cretostimogene in BCG-unresponsive Bladder Cancer Publish in Lancet Oncology

Reuters
·
Jul 28

CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170

Reuters
·
Jul 18

Ani Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Reuters
·
Jul 17

ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter

TIPRANKS
·
Jul 17

ANI Pharma Plans Delaware Supreme Court Appeal in CG Oncology Dispute

Reuters
·
Jul 17

CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million

Reuters
·
Jul 15

CG Oncology (CGON) In Focus Following Early Trial Results And BLA Timing Questions On Value

Simply Wall St.
·
Jul 14

Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON)

TIPRANKS
·
Jul 10

CG Oncology Posts Investor Deck Highlighting Cretostimogene Data in Non-muscle Invasive Bladder Cancer Trials

Reuters
·
Jul 01

Top Insider Makes Massive Bet on CG Oncology’s Future

TIPRANKS
·
Jun 30

CG Oncology Director Brian Guan-chyun Liu Reports Purchase of $24.81 Million in Common Shares

Reuters
·
Jun 30

CG Oncology Director Leonard Post Disposes of 5,000 Common Shares Worth $350,000

Reuters
·
Jun 26

CG Oncology 1.15M share Block Trade; price range $66.87-$67.87

TIPRANKS
·
Jun 25

CG Oncology director Leonard Post disposes of 5,000 shares for $325,000

Reuters
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), CG Oncology, Inc. (CGON)

TIPRANKS
·
Jun 21

CG Oncology director James Mulay disposes of 1,964 common shares worth $118,795.68

Reuters
·
Jun 17

CG Oncology Shareholders Back Directors and Governance Proposals

TIPRANKS
·
Jun 09

CG Oncology shareholders elect Class II directors at annual meeting

Reuters
·
Jun 09

CG Oncology director Leonard Post sells 1,000 shares for $54,500

Reuters
·
Jun 06

CG Oncology to Present at Upcoming Investor Conferences in June

GlobeNewswire
·
May 29